The company's catheter is designed to improve patient outcomes and clinical workflows by providing a more accurate method for stent selection. The traditional method of stent sizing relies on "eyeball" estimations, which have an inaccuracy rate of over 70%. This results in poor health outcomes, including restenosis and thrombosis, and increased healthcare expenditure. Stelect's sensor technology aims to aid clinicians in making more informed decisions by designing and licensing the smallest, high-resolution ultrasound medical imaging sensor. The company has won multiple awards for its innovative approach to improving health outcomes and lowering overall costs.